Holen Sie sich die Stockscreener-App
75.42
2.71%
-2.10
Schlusskurs vom Vortag:
$77.52
Offen:
$76.83
24-Stunden-Volumen:
1.44M
Relative Volume:
1.01
Marktkapitalisierung:
$10.24B
Einnahmen:
$3.10B
Nettoeinkommen (Verlust:
$586.71M
KGV:
17.57
EPS:
4.2937
Netto-Cashflow:
$605.57M
1W Leistung:
-6.73%
1M Leistung:
-1.59%
6M Leistung:
-11.33%
1J Leistung:
+29.72%
1-Tages-Spanne:
$74.67
$77.09
1-Wochen-Bereich:
$74.67
$81.59
52-Wochen-Spanne:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
75.42 | 10.50B | 3.10B | 586.71M | 605.57M | 4.2937 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Hochstufung | Needham | Hold → Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2025-11-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-11-07 | Hochstufung | Truist | Hold → Buy |
| 2025-10-28 | Fortgesetzt | Stifel | Hold |
| 2025-05-27 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Is Globus Medical Inc (GMED) a Bargain After 3.8% Drop? GF Value Says Undervalued - GuruFocus
GMED Maintained by Piper Sandler -- Price Target Lowered to $100 - GuruFocus
Here's How Innovation Fuels Globus Medical's Growth Momentum - Yahoo Finance UK
Madison Small Cap Fund Sold Globus Medical (GMED) as Valuation Exceeded - Yahoo Finance
Is It Time To Reassess Globus Medical (GMED) After Its Recent Share Price Recovery? - Yahoo Finance
A Look At Globus Medical (GMED) Valuation After Q1 Beat And Upgraded Full-Year Guidance - Yahoo Finance
Globus Medical (NYSE:GMED) Shines in Navellier's Little Book Growth Stock Screen - ChartMill
Globus Medical Inc (GMED) Stock Up 5.4% and Still Undervalued -- GF Score: 97/100 - GuruFocus
Here is Why Globus Medical (GMED) is One of the Most Profitable Growth Stocks to Buy - Insider Monkey
Globus Medical Director Sold Shares Worth Over $2M - TradingView
Globus Medical Insider Sold Shares Worth $2,019,073, According to a Recent SEC Filing - marketscreener.com
Globus Medical (NYSE: GMED) director exercises options, sells 25,000 shares - Stock Titan
Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom - TradingView
Piper Sandler reiterates Globus Medical stock rating on robot patent By Investing.com - Investing.com Canada
Globus Medical (GMED) director exercises options for 25,000 new shares - Stock Titan
2 Reasons to Watch GMED and 1 to Stay Cautious - Yahoo Finance UK
Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now - TradingView
Does Globus Medical (GMED) Have the Potential to Rally 38.85% as Wall Street Analysts Expect? - Yahoo Finance
Globus Medical, Inc. (GMED) A Cheap Robotics Stock Firing on Earnings and Revenue Growth - Insider Monkey
Pretax income of Globus Medical Inc Class A – XETR:GM0N - TradingView
Tangible book value per share of Globus Medical Inc Class A – XETR:GM0N - TradingView
Long term debt to total equity ratio of Globus Medical Inc Class A – XETR:GM0N - TradingView
Total assets of Globus Medical Inc Class A – XETR:GM0N - TradingView
Operating expenses (excl. COGS) of Globus Medical Inc Class A – XETR:GM0N - TradingView
Here's why Globus Medical (GMED) is a strong value stock - MSN
Globus Medical Inc Class A Trade Ideas — XETR:GM0N - TradingView
[144] GLOBUS MEDICAL INC SEC Filing - Stock Titan
A Look At Globus Medical (GMED) Valuation After Recent Share Price Weakness - Sahm
Life Spine Announces “Total Victory” in Patent Battle with Globus - Ortho Spine News
Here's Why Globus Medical (GMED) is a Strong Value Stock - Yahoo Finance
Life Spine earns patent spat victory over Globus Medical - MassDevice
[8-K] GLOBUS MEDICAL INC Reports Material Event - Stock Titan
Life Spine Wins Appeal Wiping Out Globus Implant Patent Claims - Bloomberg Law News
Globus Medical (GMED) Is Down 5.6% After Pivoting Excelsius Robotics To Leasing ModelHas The Bull Case Changed? - Yahoo Finance
Globus Medical: Obtaining My Backing Again - Seeking Alpha
Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom? - TradingView
Globus Medical Rethinks Robotics Revenue Model As FDA Approvals Broaden Story - Yahoo Finance
Law firm investigates Globus Medical for possible breach of fiduciary duties by directors. - Pluang
Medical Devices & SuppliesSpecialty Stocks Q1 Teardown: Globus Medical (NYSE:GMED) Vs The Rest - Yahoo Finance
Globus Medical (GMED) upgraded to strong buy: Here's what you should know - MSN
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Globus Medical, Inc. (NYSE: GMED) - PR Newswire
Globus Medical, Inc. (GMED): Investor Outlook And Potential 34% Upside - DirectorsTalk Interviews
Globus Medical Inc stock (US3795772082): Q1 2026 earnings and guidance in focus after recent price c - AD HOC NEWS
Number of shareholders of Globus Medical Inc Class A – BX:GMED - TradingView
Globus Medical Inc stock (US3795772082): valuation metrics in focus after robotics leasing update - AD HOC NEWS
Spotting Winners: Inspire Medical Systems (NYSE:INSP) And Medical Devices & SuppliesSpecialty Stocks In Q1 - Yahoo Finance
Teladoc Health Broadens Virtual Care Reach Through Walmart Platform - TradingView
GMED's Robotics Leasing Shift Could Build Recurring Revenue - TradingView
Globus Medical IncA (NYSE:GMED) Shines in Decent Value Screen with Strong Fundamentals - ChartMill
GMED Growth Drivers After NuVasive and What Q1 Signals - TradingView
Globus Medical Inc (GMED) Shares Fall 3.0% -- What GF Score of 9 - GuruFocus
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):